Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 7 Colorectal Neoplasms 7 Neoplasms 6 Breast Neoplasms 6 Lung Neoplasms 4 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 End Stage Liver Disease 2 Warts 1 Urinary Bladder Neoplasms 1 Tinea 1 Smoking 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Nevus 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Molluscum Contagiosum 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Cancer Screening 1 Liver Neoplasms 1 Kidney Failure, Chronic 1 Keratosis, Actinic 1 Intestinal Neoplasms 1 Impetigo 1 Herpes Zoster 1 Hepatitis C 1 Heart Diseases 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Blood Specimen Collection 6 Prednisone 5 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Exercise 3 Biopsy 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Educational Status 2 Doxorubicin 2 Cytarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Mass Screening × Clear all

NCT04590560 2024-12-09

MISS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Recruiting

60,000 enrolled

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡